Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

Biotech companies are using a new set of artificial intelligence products to hasten drug discovery and other scientific ...

A 55-year-old Chinese man was accidentally swept more than 28,000 feet over Northwest China while testing a paraglider harness. A powerful updraft of wind lifted him far above the tallest buildings in ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Eli Lilly acquires SiteOne Therapeutics for up to $1 billion, signaling potential uptick in Big Pharma deals and focus on ...

Dan Heapy brings strategic marketing expertise to critically assess the approaches taken by the biotech companies – and offers recommendations for future biotech development. With the ever ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

High energy demands and social acceptance remain key barriers to scaling. Scientists reveal futuristic farming technique that ...

ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.